These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program. Cavarzere P, Camilot M, Teofoli F, Tatò L. Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055 [Abstract] [Full Text] [Related]
12. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia. van der Linde AAA, Schönbeck Y, van der Kamp HJ, van den Akker ELT, van Albada ME, Boelen A, Finken MJJ, Hannema SE, Hoorweg-Nijman G, Odink RJ, Schielen PCJI, Straetemans S, van Trotsenburg PS, Claahsen-van der Grinten HL, Verkerk PH. Arch Dis Child; 2019 Jul; 104(7):653-657. PubMed ID: 30712004 [Abstract] [Full Text] [Related]
17. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants. Güran T, Tezel B, Çakır M, Akıncı A, Orbak Z, Keskin M, Selver Eklioğlu B, Ozon A, Özbek MN, Karagüzel G, Hatipoğlu N, Gürbüz F, Çizmecioğlu FM, Kara C, Şimşek E, Baş F, Aydın M, Darendeliler F. J Clin Res Pediatr Endocrinol; 2020 Sep 02; 12(3):287-294. PubMed ID: 32157855 [Abstract] [Full Text] [Related]
18. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S. Pediatrics; 1998 Apr 02; 101(4 Pt 1):583-90. PubMed ID: 9521938 [Abstract] [Full Text] [Related]